Tower Research Capital (TRC)’s Lifestance Health LFST Stock Holding History
Bought
Maintained
Sold
Other funds holding LFST
Tower Research Capital (TRC)'s LFST Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Lifestance Health (LFST) stake by 27% in Q3 2026, buying an estimated $25.2K and bringing the position to 10,047 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #2697.
Tower Research Capital (TRC) first reported a position in LFST in Q2 2021 and has held it in 22 quarters since. The position peaked at $188K in Q4 2023. 324 funds tracked by Wall St. Rank hold LFST as of Q3 2026.
- Tower Research Capital (TRC) held 10,047 shares of Lifestance Health worth $121K as of Q3 2026.
- Tower Research Capital (TRC) bought 2,135 Lifestance Health shares in Q3 2026, an estimated $25.2K.
- Lifestance Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #2697 holding.
- Tower Research Capital (TRC) first reported a position in Lifestance Health in Q2 2021 and has held it in 22 quarters since.
- Tower Research Capital (TRC)'s Lifestance Health position peaked at $188K in Q4 2023.
- 324 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.